Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Queen's University Belfast's scientists and Almac Discovery have developed a new cancer treatment which helps in the prevention of growth of new blood vessels in tumours, starving them of oxygen and nutrients, and prevents their growth.
Subscribe to our email newsletter
The new cancer treatment also attracts tumours directly.
Tracy Robson and her research team at Queen’s, in collaboration with researchers at Almac Discovery, developed a new drug to disrupt the tumour blood supply.
Almac Discovery is developing the drug candidate and expects to initiate clinical trials within the next year.
Queen’s School of Pharmacy professor Tracy Robson said understanding the anti-angiogenic potential of the natural protein, FKBPL, they have been able to develop small peptide-based drugs that could be delivered to prevent tumour growth by cutting off their blood supply. This is effective in models of prostate and breast cancer.